Editor(s):

(1) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Arta Dodaj, University of Zadar, Croatia.

(2) Ibrahim  El-Zraigat, The University of Jordan, Jordan.

Additional Reviewers:

(1) Noor Lela Ahmad, Sultan Idris University of Education, Malaysia.

(2) Tatiani Gkatsa, University of Ioannina, Greece.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Arta Dodaj, Croatia) | File 1 | NA

Stage 2 | Peer review report_2 (Ibrahim  El-Zraigat, Jordan) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. R. Deveswaran, Associate Professor & Head, Drug Design and Development Centre, Faculty of Pharmacy, M.S.Ramaiah University of Applied Sciences, India.

(2) Dr. Dharmesh Chandra Sharma,ABTO ( Associate Blood Transfusion Officer), Incharge Blood Bank, Component & Aphaeresis Uni, G. R. Medical College & J. A. Hospital, Gwalior India.

Reviewers:

(1) Aderemi Moses Adewale, Alvan Ikoku Federal College of Education Owerri, Nigeria.

(2) Mônica Barbosa de Sousa Freitas, Florida Christian University – FCU, Florida.

Additional Reviewers:

(1) Getu Teferi, Debremarkos University, Ethiopia.

(2) Arc. Onwukwe, Federal Polytechnic Nekede Owerri, Nigeria.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.2/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Aderemi Moses Adewale, Nigeria) | File 1 | File 2

Stage 2 | Peer review report_2 (Mônica Barbosa de Sousa Freitas, Florida) | File 1 | File 2

Stage 2 | Journal Change | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems Propharmex Company, India.

(2) Dr. Debarshi Kar Mahapatra, Assistant Professor, Dadasaheb Balpande College of Pharmacy Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, India.

Reviewers:

(1) Kiril Stefanov Slaveykov, Trakia University, Bulgaria.

(2) Manoj Kumar Saurabh, All India Institute of Medical Sciences, India.

(3) Manoranjan Dash, Siksha O Anusandhan University, India.

Additional Reviewers:

(1) Hanifah Rahmi Fajrin, Universitas Muhammadiyah Yogyakarta, Indonesia.

(2) Mudasir M Kirmani, SK Unviersity of Agricultural Sciences and technology of Kashmir, India.

(3) Zvezdan Stojanović, PIM University and European University, Bosnia and Herzegovina.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Kiril Stefanov Slaveykov, Bulgaria) | File 1 | File 2

Stage 2 | Peer review report_2 (Manoj Kumar Saurabh, India) | File 1 | NA

Stage 2 | Peer review report_3 (Manoranjan Dash, India) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA

Editor(s):

(1) Dr. Giuseppe Murdaca, Clinical Immunology Unit, University of Genoa, Italy.

Reviewers:

(1) Sakshi Kadian, AIIMS Rishikesh, India.

(2) Azarinah Izaham, Universiti Kebangsaan Malaysia, Malaysia

(3)

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Sakshi Kadian, India) | File 1 | NA

Stage 2 | Peer review report_2 (Azarinah Izaham, Malaysia) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portuga.

Reviewers:

(1) Grzegorz Zieliński, Medical University of Lublin, Poland.

(2) Bülent Bayraktar, Bayburt University,Turkey.

Additional Reviewers:

(1) Ilaria Capozzi, Italy.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Grzegorz Zieliński, Poland) | File 1 | NA

Stage 2 | Peer review report_2 (Bülent Bayraktar, Turkey) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Perugia, Italy.

Reviewers:

(1) Durgaprasad Kemisetti, Assam Down Town University, India.

(2) Marwan Thaer Jalal, Tikrit University, Iraq.

Additional Reviewers:

(1) Bhogaraju Anand, Malla Reddy Institute of Medical Sciences, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Durgaprasad Kemisetti, India) | File 1 | File 2

Stage 2 | Peer review report_2 (Marwan Thaer Jalal, Iraq) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine

Reviewers:

(1) F. Solano, University of Murcia, Spain

(2) Francisco Javier Torres Gómez, Utrera High Resolution Hospital, Spain

(3)

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.75/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (F. Solano, Spain) | File 1 | NA

Stage 2 | Peer review report_2 (Francisco Javier Torres Gómez, Spain) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Rafik Karaman,Professor, College of Pharmacy, Al-Quds University, Jerusalem, Palestine.

Reviewers:

(1) Kenza Benzeroual, LIU, USA.

(2) Pallavi Wakode, SKNCOPT, India.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Kenza Benzeroual, USA) | File 1 | File 2

Stage 2 | Peer review report_2 (Pallavi Wakode, India) | File 1 | File 2

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Ana Cláudia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Munira Hirkani, Seth GSMC & KEMH, India.

(2) Pentti Nieminen, University of Oulu, Finland.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 6/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Munira Hirkani, India) | File 1 | NA

Stage 2 | Peer review report_2 (Pentti Nieminen, Finland) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Editor(s):

(1) Dr. Fahmida Khan, National Institute of Technology Raipur, India.

(2) Dr. Syed A. A. Rizvi, Nova Southeastern University, USA.

Reviewers:

(1) Carlos Hernan Herrera Mendez, Universidad De Guanajuato, Mexico.

(2) Hoang Viet Bach, National Cancer Hospital, Vietnam.

Additional Reviewers:

Open Peer Review Policy: Click Here

Specific Comment:

The peer review history will be available very soon.

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer review report_1 (Carlos Hernan Herrera Mendez, Mexico) | File 1 | NA

Stage 2 | Peer review report_2 (Hoang Viet Bach, Vietnam) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA